nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—osteoporosis	0.42	0.569	CbGaD
Amifostine—ALPL—osteoporosis	0.318	0.431	CbGaD
Amifostine—ALPPL2—epiphyseal plate—osteoporosis	0.021	0.191	CbGeAlD
Amifostine—ENPP1—Vitamin B2 (riboflavin) metabolism—ACP5—osteoporosis	0.0179	0.29	CbGpPWpGaD
Amifostine—ALPPL2—forelimb zeugopod—osteoporosis	0.0168	0.153	CbGeAlD
Amifostine—ALPPL2—mandible—osteoporosis	0.0167	0.152	CbGeAlD
Amifostine—ALPPL2—jaw skeleton—osteoporosis	0.0142	0.129	CbGeAlD
Amifostine—ALPPL2—periosteum—osteoporosis	0.0107	0.0974	CbGeAlD
Amifostine—ALPPL2—vertebral column—osteoporosis	0.00886	0.0807	CbGeAlD
Amifostine—ALPPL2—skull—osteoporosis	0.00878	0.08	CbGeAlD
Amifostine—ALPPL2—parathyroid gland—osteoporosis	0.00858	0.0782	CbGeAlD
Amifostine—ALPL—Endochondral Ossification—PTH1R—osteoporosis	0.00444	0.0719	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—PTH1R—osteoporosis	0.00378	0.0611	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—PTH—osteoporosis	0.00233	0.0378	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—PTH—osteoporosis	0.00198	0.0321	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—PTHLH—osteoporosis	0.00193	0.0313	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—ALPL—osteoporosis	0.00187	0.0303	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	0.00183	0.0295	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—CAP1—osteoporosis	0.00182	0.0294	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—PTHLH—osteoporosis	0.00164	0.0266	CbGpPWpGaD
Amifostine—ENPP1—uterus—osteoporosis	0.00152	0.0138	CbGeAlD
Amifostine—ALPPL2—uterus—osteoporosis	0.00146	0.0133	CbGeAlD
Amifostine—ALPPL2—bone marrow—osteoporosis	0.00124	0.0113	CbGeAlD
Amifostine—ALPL—BDNF signaling pathway—RAP1A—osteoporosis	0.0012	0.0194	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—AGER—osteoporosis	0.00119	0.0192	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—SPP1—osteoporosis	0.00117	0.019	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—BMP2—osteoporosis	0.00101	0.0164	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—SPP1—osteoporosis	0.000996	0.0161	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—IRS1—osteoporosis	0.000903	0.0146	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—IGF1—osteoporosis	0.000857	0.0139	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.000741	0.012	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF1—osteoporosis	0.000729	0.0118	CbGpPWpGaD
Amifostine—Arrhythmia—Calcium Acetate—osteoporosis	0.000667	0.00735	CcSEcCtD
Amifostine—Anaphylactoid reaction—Estropipate—osteoporosis	0.000633	0.00698	CcSEcCtD
Amifostine—Hypocalcaemia—Zoledronate—osteoporosis	0.000633	0.00697	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—SPP1—osteoporosis	0.000612	0.00991	CbGpPWpGaD
Amifostine—Hypocalcaemia—Conjugated Estrogens—osteoporosis	0.000609	0.00671	CcSEcCtD
Amifostine—Syncope—Calcium Acetate—osteoporosis	0.000583	0.00642	CcSEcCtD
Amifostine—Loss of consciousness—Calcium Acetate—osteoporosis	0.000571	0.00629	CcSEcCtD
Amifostine—Myocardial ischaemia—Estradiol—osteoporosis	0.000555	0.00612	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—IRS2—osteoporosis	0.000554	0.00896	CbGpPWpGaD
Amifostine—Rigors—Estradiol—osteoporosis	0.000547	0.00602	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Alendronate—osteoporosis	0.000543	0.00599	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Etidronic acid—osteoporosis	0.000541	0.00596	CcSEcCtD
Amifostine—Shock—Calcium Acetate—osteoporosis	0.000522	0.00575	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—TGFB1—osteoporosis	0.000514	0.00831	CbGpPWpGaD
Amifostine—Chest discomfort—Estradiol—osteoporosis	0.000505	0.00556	CcSEcCtD
Amifostine—Hypertension—Ergocalciferol—osteoporosis	0.000496	0.00546	CcSEcCtD
Amifostine—Hypotension—Calcium Acetate—osteoporosis	0.000496	0.00546	CcSEcCtD
Amifostine—Hypocalcaemia—Estradiol—osteoporosis	0.000488	0.00537	CcSEcCtD
Amifostine—Atrial fibrillation—Pamidronate—osteoporosis	0.000486	0.00535	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—IRS1—osteoporosis	0.000484	0.00783	CbGpPWpGaD
Amifostine—Anaphylactoid reaction—Pamidronate—osteoporosis	0.000476	0.00524	CcSEcCtD
Amifostine—Acute coronary syndrome—Estropipate—osteoporosis	0.000466	0.00513	CcSEcCtD
Amifostine—Erythema multiforme—Etidronic acid—osteoporosis	0.000463	0.0051	CcSEcCtD
Amifostine—Myocardial infarction—Estropipate—osteoporosis	0.000463	0.0051	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.000461	0.00508	CcSEcCtD
Amifostine—Renal failure—Ibandronate—osteoporosis	0.000445	0.0049	CcSEcCtD
Amifostine—Atrial fibrillation—Zoledronate—osteoporosis	0.000444	0.00489	CcSEcCtD
Amifostine—Feeling abnormal—Calcium Acetate—osteoporosis	0.000437	0.00481	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—TGFB1—osteoporosis	0.000437	0.00707	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—IRS2—osteoporosis	0.000433	0.00701	CbGpPWpGaD
Amifostine—Anaphylactoid reaction—Conjugated Estrogens—osteoporosis	0.000418	0.00461	CcSEcCtD
Amifostine—Erythema multiforme—Estropipate—osteoporosis	0.000401	0.00442	CcSEcCtD
Amifostine—Erythema multiforme—Alendronate—osteoporosis	0.000395	0.00435	CcSEcCtD
Amifostine—Hypersensitivity—Calcium Acetate—osteoporosis	0.000391	0.0043	CcSEcCtD
Amifostine—ENPP1—Disease—PKM—osteoporosis	0.000387	0.00626	CbGpPWpGaD
Amifostine—ENPP1—Disease—SOST—osteoporosis	0.000387	0.00626	CbGpPWpGaD
Amifostine—Flushing—Raloxifene—osteoporosis	0.000381	0.0042	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—IRS1—osteoporosis	0.000378	0.00612	CbGpPWpGaD
Amifostine—Acute coronary syndrome—Ethinyl Estradiol—osteoporosis	0.000377	0.00416	CcSEcCtD
Amifostine—Erythema multiforme—Calcitriol—osteoporosis	0.000376	0.00415	CcSEcCtD
Amifostine—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.000375	0.00413	CcSEcCtD
Amifostine—Pruritus—Calcium Acetate—osteoporosis	0.000375	0.00413	CcSEcCtD
Amifostine—ENPP1—Disease—PGLS—osteoporosis	0.000367	0.00593	CbGpPWpGaD
Amifostine—ENPP1—Disease—ANTXR2—osteoporosis	0.000367	0.00593	CbGpPWpGaD
Amifostine—Chills—Ibandronate—osteoporosis	0.000365	0.00402	CcSEcCtD
Amifostine—Discomfort—Etidronic acid—osteoporosis	0.000359	0.00395	CcSEcCtD
Amifostine—Arrhythmia—Calcitriol—osteoporosis	0.000355	0.00392	CcSEcCtD
Amifostine—Dizziness—Calcium Acetate—osteoporosis	0.000351	0.00386	CcSEcCtD
Amifostine—Renal failure—Pamidronate—osteoporosis	0.000349	0.00384	CcSEcCtD
Amifostine—Ill-defined disorder—Alendronate—osteoporosis	0.000337	0.00372	CcSEcCtD
Amifostine—Vomiting—Calcium Acetate—osteoporosis	0.000337	0.00371	CcSEcCtD
Amifostine—Anaphylactoid reaction—Estradiol—osteoporosis	0.000335	0.00369	CcSEcCtD
Amifostine—Ill-defined disorder—Ibandronate—osteoporosis	0.000328	0.00362	CcSEcCtD
Amifostine—Malaise—Alendronate—osteoporosis	0.000328	0.00361	CcSEcCtD
Amifostine—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000325	0.00358	CcSEcCtD
Amifostine—ENPP1—Metabolism—FDPS—osteoporosis	0.000324	0.00524	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PKM—osteoporosis	0.000324	0.00524	CbGpPWpGaD
Amifostine—Syncope—Raloxifene—osteoporosis	0.000321	0.00353	CcSEcCtD
Amifostine—Malaise—Ibandronate—osteoporosis	0.000319	0.00352	CcSEcCtD
Amifostine—Renal failure—Zoledronate—osteoporosis	0.000319	0.00351	CcSEcCtD
Amifostine—Nausea—Calcium Acetate—osteoporosis	0.000315	0.00347	CcSEcCtD
Amifostine—Loss of consciousness—Raloxifene—osteoporosis	0.000314	0.00346	CcSEcCtD
Amifostine—ENPP1—Disease—GSN—osteoporosis	0.000312	0.00505	CbGpPWpGaD
Amifostine—Chest pain—Alendronate—osteoporosis	0.000309	0.00341	CcSEcCtD
Amifostine—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.000308	0.00339	CcSEcCtD
Amifostine—ENPP1—Metabolism—PGLS—osteoporosis	0.000307	0.00497	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GPD2—osteoporosis	0.000307	0.00497	CbGpPWpGaD
Amifostine—Renal failure—Conjugated Estrogens—osteoporosis	0.000307	0.00338	CcSEcCtD
Amifostine—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.000306	0.00337	CcSEcCtD
Amifostine—Discomfort—Alendronate—osteoporosis	0.000306	0.00337	CcSEcCtD
Amifostine—Hypertension—Ibandronate—osteoporosis	0.000306	0.00337	CcSEcCtD
Amifostine—Chest pain—Raloxifene—osteoporosis	0.000304	0.00335	CcSEcCtD
Amifostine—Chest pain—Ibandronate—osteoporosis	0.000301	0.00332	CcSEcCtD
Amifostine—Anaphylactic shock—Estropipate—osteoporosis	0.000301	0.00332	CcSEcCtD
Amifostine—Convulsion—Calcitriol—osteoporosis	0.0003	0.00331	CcSEcCtD
Amifostine—Arrhythmia—Risedronate—osteoporosis	0.000299	0.0033	CcSEcCtD
Amifostine—Hypertension—Calcitriol—osteoporosis	0.000299	0.0033	CcSEcCtD
Amifostine—Discomfort—Ibandronate—osteoporosis	0.000298	0.00328	CcSEcCtD
Amifostine—Bradycardia—Zoledronate—osteoporosis	0.000296	0.00326	CcSEcCtD
Amifostine—Flushing—Pamidronate—osteoporosis	0.000296	0.00326	CcSEcCtD
Amifostine—Chest pain—Calcitriol—osteoporosis	0.000295	0.00325	CcSEcCtD
Amifostine—Discomfort—Calcitriol—osteoporosis	0.000291	0.00321	CcSEcCtD
Amifostine—Anaphylactic shock—Ibandronate—osteoporosis	0.000289	0.00318	CcSEcCtD
Amifostine—Shock—Raloxifene—osteoporosis	0.000287	0.00316	CcSEcCtD
Amifostine—Feeling abnormal—Etidronic acid—osteoporosis	0.000287	0.00316	CcSEcCtD
Amifostine—Chills—Pamidronate—osteoporosis	0.000286	0.00315	CcSEcCtD
Amifostine—Shock—Ibandronate—osteoporosis	0.000284	0.00313	CcSEcCtD
Amifostine—Anaphylactic shock—Calcitriol—osteoporosis	0.000283	0.00311	CcSEcCtD
Amifostine—ENPP1—Metabolism—ATIC—osteoporosis	0.000281	0.00455	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PNP—osteoporosis	0.000281	0.00455	CbGpPWpGaD
Amifostine—Nausea—Ergocalciferol—osteoporosis	0.000278	0.00307	CcSEcCtD
Amifostine—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000278	0.00306	CcSEcCtD
Amifostine—Urticaria—Etidronic acid—osteoporosis	0.000277	0.00305	CcSEcCtD
Amifostine—ENPP1—Disease—LRP5—osteoporosis	0.000271	0.00439	CbGpPWpGaD
Amifostine—Flushing—Zoledronate—osteoporosis	0.00027	0.00297	CcSEcCtD
Amifostine—Malaise—Ethinyl Estradiol—osteoporosis	0.00027	0.00297	CcSEcCtD
Amifostine—Somnolence—Estropipate—osteoporosis	0.000268	0.00295	CcSEcCtD
Amifostine—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000265	0.00292	CcSEcCtD
Amifostine—Syncope—Risedronate—osteoporosis	0.000262	0.00288	CcSEcCtD
Amifostine—Chills—Zoledronate—osteoporosis	0.000261	0.00288	CcSEcCtD
Amifostine—Arrhythmia—Zoledronate—osteoporosis	0.00026	0.00286	CcSEcCtD
Amifostine—ENPP1—Disease—LRP6—osteoporosis	0.000259	0.0042	CbGpPWpGaD
Amifostine—Ill-defined disorder—Pamidronate—osteoporosis	0.000257	0.00283	CcSEcCtD
Amifostine—Hypersensitivity—Etidronic acid—osteoporosis	0.000256	0.00283	CcSEcCtD
Amifostine—Loss of consciousness—Risedronate—osteoporosis	0.000256	0.00282	CcSEcCtD
Amifostine—Hypertension—Risedronate—osteoporosis	0.000252	0.00277	CcSEcCtD
Amifostine—Discomfort—Ethinyl Estradiol—osteoporosis	0.000252	0.00277	CcSEcCtD
Amifostine—Somnolence—Calcitriol—osteoporosis	0.000251	0.00277	CcSEcCtD
Amifostine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00025	0.00276	CcSEcCtD
Amifostine—Malaise—Pamidronate—osteoporosis	0.00025	0.00275	CcSEcCtD
Amifostine—ENPP1—Disease—RPL24—osteoporosis	0.000249	0.00403	CbGpPWpGaD
Amifostine—ENPP1—Disease—LTF—osteoporosis	0.000249	0.00403	CbGpPWpGaD
Amifostine—Syncope—Pamidronate—osteoporosis	0.000249	0.00274	CcSEcCtD
Amifostine—Chest pain—Risedronate—osteoporosis	0.000248	0.00274	CcSEcCtD
Amifostine—Pruritus—Etidronic acid—osteoporosis	0.000246	0.00271	CcSEcCtD
Amifostine—Acute coronary syndrome—Estradiol—osteoporosis	0.000246	0.00271	CcSEcCtD
Amifostine—Myocardial infarction—Estradiol—osteoporosis	0.000245	0.0027	CcSEcCtD
Amifostine—Feeling abnormal—Alendronate—osteoporosis	0.000244	0.00269	CcSEcCtD
Amifostine—Loss of consciousness—Pamidronate—osteoporosis	0.000244	0.00268	CcSEcCtD
Amifostine—Convulsion—Pamidronate—osteoporosis	0.00024	0.00265	CcSEcCtD
Amifostine—Hypertension—Pamidronate—osteoporosis	0.000239	0.00264	CcSEcCtD
Amifostine—Urticaria—Estropipate—osteoporosis	0.000239	0.00264	CcSEcCtD
Amifostine—ENPP1—Metabolism—CA2—osteoporosis	0.000239	0.00386	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—OXCT1—osteoporosis	0.000239	0.00386	CbGpPWpGaD
Amifostine—Body temperature increased—Estropipate—osteoporosis	0.000238	0.00262	CcSEcCtD
Amifostine—Feeling abnormal—Ibandronate—osteoporosis	0.000238	0.00262	CcSEcCtD
Amifostine—Urticaria—Alendronate—osteoporosis	0.000236	0.0026	CcSEcCtD
Amifostine—Ill-defined disorder—Zoledronate—osteoporosis	0.000235	0.00259	CcSEcCtD
Amifostine—Body temperature increased—Alendronate—osteoporosis	0.000234	0.00258	CcSEcCtD
Amifostine—Shock—Risedronate—osteoporosis	0.000234	0.00258	CcSEcCtD
Amifostine—Discomfort—Pamidronate—osteoporosis	0.000233	0.00257	CcSEcCtD
Amifostine—ENPP1—Metabolism—MGLL—osteoporosis	0.000233	0.00377	CbGpPWpGaD
Amifostine—Body temperature increased—Raloxifene—osteoporosis	0.000231	0.00254	CcSEcCtD
Amifostine—Urticaria—Ibandronate—osteoporosis	0.000229	0.00253	CcSEcCtD
Amifostine—Malaise—Zoledronate—osteoporosis	0.000228	0.00252	CcSEcCtD
Amifostine—Body temperature increased—Ibandronate—osteoporosis	0.000228	0.00252	CcSEcCtD
Amifostine—Syncope—Zoledronate—osteoporosis	0.000227	0.0025	CcSEcCtD
Amifostine—Anaphylactic shock—Pamidronate—osteoporosis	0.000226	0.00249	CcSEcCtD
Amifostine—Urticaria—Calcitriol—osteoporosis	0.000225	0.00247	CcSEcCtD
Amifostine—Body temperature increased—Calcitriol—osteoporosis	0.000223	0.00246	CcSEcCtD
Amifostine—Shock—Pamidronate—osteoporosis	0.000223	0.00245	CcSEcCtD
Amifostine—Loss of consciousness—Zoledronate—osteoporosis	0.000223	0.00245	CcSEcCtD
Amifostine—Hypersensitivity—Estropipate—osteoporosis	0.000222	0.00244	CcSEcCtD
Amifostine—Vomiting—Etidronic acid—osteoporosis	0.000221	0.00244	CcSEcCtD
Amifostine—Tachycardia—Pamidronate—osteoporosis	0.000221	0.00243	CcSEcCtD
Amifostine—Rash—Etidronic acid—osteoporosis	0.00022	0.00242	CcSEcCtD
Amifostine—Convulsion—Zoledronate—osteoporosis	0.000219	0.00242	CcSEcCtD
Amifostine—Dermatitis—Etidronic acid—osteoporosis	0.000219	0.00242	CcSEcCtD
Amifostine—Syncope—Conjugated Estrogens—osteoporosis	0.000219	0.00241	CcSEcCtD
Amifostine—Hypertension—Zoledronate—osteoporosis	0.000219	0.00241	CcSEcCtD
Amifostine—Hypersensitivity—Alendronate—osteoporosis	0.000219	0.00241	CcSEcCtD
Amifostine—ENPP1—Disease—ACP5—osteoporosis	0.000216	0.0035	CbGpPWpGaD
Amifostine—Chest pain—Zoledronate—osteoporosis	0.000216	0.00238	CcSEcCtD
Amifostine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000214	0.00236	CcSEcCtD
Amifostine—Pruritus—Estropipate—osteoporosis	0.000213	0.00235	CcSEcCtD
Amifostine—Discomfort—Zoledronate—osteoporosis	0.000213	0.00235	CcSEcCtD
Amifostine—Hypersensitivity—Ibandronate—osteoporosis	0.000213	0.00234	CcSEcCtD
Amifostine—Dyspnoea—Risedronate—osteoporosis	0.000212	0.00234	CcSEcCtD
Amifostine—Erythema multiforme—Estradiol—osteoporosis	0.000212	0.00234	CcSEcCtD
Amifostine—Hypotension—Pamidronate—osteoporosis	0.000211	0.00233	CcSEcCtD
Amifostine—Convulsion—Conjugated Estrogens—osteoporosis	0.000211	0.00233	CcSEcCtD
Amifostine—Pruritus—Alendronate—osteoporosis	0.00021	0.00231	CcSEcCtD
Amifostine—Hypersensitivity—Calcitriol—osteoporosis	0.000208	0.00229	CcSEcCtD
Amifostine—Flushing—Estradiol—osteoporosis	0.000208	0.00229	CcSEcCtD
Amifostine—Chest pain—Conjugated Estrogens—osteoporosis	0.000208	0.00229	CcSEcCtD
Amifostine—Nausea—Etidronic acid—osteoporosis	0.000207	0.00228	CcSEcCtD
Amifostine—Anaphylactic shock—Zoledronate—osteoporosis	0.000207	0.00228	CcSEcCtD
Amifostine—Pruritus—Ibandronate—osteoporosis	0.000204	0.00225	CcSEcCtD
Amifostine—Shock—Zoledronate—osteoporosis	0.000203	0.00224	CcSEcCtD
Amifostine—Dyspnoea—Pamidronate—osteoporosis	0.000202	0.00222	CcSEcCtD
Amifostine—Tachycardia—Zoledronate—osteoporosis	0.000202	0.00222	CcSEcCtD
Amifostine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000201	0.00222	CcSEcCtD
Amifostine—Chills—Estradiol—osteoporosis	0.000201	0.00222	CcSEcCtD
Amifostine—Somnolence—Pamidronate—osteoporosis	0.000201	0.00222	CcSEcCtD
Amifostine—ENPP1—Disease—TPI1—osteoporosis	0.000201	0.00325	CbGpPWpGaD
Amifostine—Pruritus—Calcitriol—osteoporosis	0.0002	0.0022	CcSEcCtD
Amifostine—Dizziness—Estropipate—osteoporosis	0.000199	0.00219	CcSEcCtD
Amifostine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000199	0.00219	CcSEcCtD
Amifostine—ENPP1—Metabolism—IDH2—osteoporosis	0.000198	0.0032	CbGpPWpGaD
Amifostine—Dizziness—Alendronate—osteoporosis	0.000196	0.00216	CcSEcCtD
Amifostine—Shock—Conjugated Estrogens—osteoporosis	0.000196	0.00216	CcSEcCtD
Amifostine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000194	0.00214	CcSEcCtD
Amifostine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000194	0.00214	CcSEcCtD
Amifostine—Hypotension—Zoledronate—osteoporosis	0.000193	0.00213	CcSEcCtD
Amifostine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000193	0.00213	CcSEcCtD
Amifostine—Dizziness—Raloxifene—osteoporosis	0.000193	0.00213	CcSEcCtD
Amifostine—Vomiting—Estropipate—osteoporosis	0.000191	0.00211	CcSEcCtD
Amifostine—Dizziness—Ibandronate—osteoporosis	0.000191	0.0021	CcSEcCtD
Amifostine—Rash—Estropipate—osteoporosis	0.00019	0.00209	CcSEcCtD
Amifostine—Dermatitis—Estropipate—osteoporosis	0.00019	0.00209	CcSEcCtD
Amifostine—Urticaria—Risedronate—osteoporosis	0.000189	0.00208	CcSEcCtD
Amifostine—ENPP1—Disease—P4HB—osteoporosis	0.000189	0.00306	CbGpPWpGaD
Amifostine—Vomiting—Alendronate—osteoporosis	0.000189	0.00208	CcSEcCtD
Amifostine—Body temperature increased—Risedronate—osteoporosis	0.000188	0.00207	CcSEcCtD
Amifostine—Rash—Alendronate—osteoporosis	0.000187	0.00206	CcSEcCtD
Amifostine—Dermatitis—Alendronate—osteoporosis	0.000187	0.00206	CcSEcCtD
Amifostine—Feeling abnormal—Pamidronate—osteoporosis	0.000186	0.00205	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP27A1—osteoporosis	0.000186	0.00301	CbGpPWpGaD
Amifostine—Hypotension—Conjugated Estrogens—osteoporosis	0.000186	0.00205	CcSEcCtD
Amifostine—Vomiting—Raloxifene—osteoporosis	0.000185	0.00204	CcSEcCtD
Amifostine—ENPP1—Disease—GAPDH—osteoporosis	0.000185	0.003	CbGpPWpGaD
Amifostine—Dyspnoea—Zoledronate—osteoporosis	0.000184	0.00203	CcSEcCtD
Amifostine—Rash—Raloxifene—osteoporosis	0.000184	0.00203	CcSEcCtD
Amifostine—Dermatitis—Raloxifene—osteoporosis	0.000184	0.00202	CcSEcCtD
Amifostine—Somnolence—Zoledronate—osteoporosis	0.000184	0.00202	CcSEcCtD
Amifostine—Vomiting—Ibandronate—osteoporosis	0.000184	0.00202	CcSEcCtD
Amifostine—Rash—Ibandronate—osteoporosis	0.000182	0.00201	CcSEcCtD
Amifostine—Dermatitis—Ibandronate—osteoporosis	0.000182	0.002	CcSEcCtD
Amifostine—Ill-defined disorder—Estradiol—osteoporosis	0.000181	0.00199	CcSEcCtD
Amifostine—ENPP1—Metabolism—ACP5—osteoporosis	0.000181	0.00293	CbGpPWpGaD
Amifostine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00018	0.00198	CcSEcCtD
Amifostine—Vomiting—Calcitriol—osteoporosis	0.00018	0.00198	CcSEcCtD
Amifostine—Nausea—Estropipate—osteoporosis	0.000179	0.00197	CcSEcCtD
Amifostine—Body temperature increased—Pamidronate—osteoporosis	0.000179	0.00197	CcSEcCtD
Amifostine—Rash—Calcitriol—osteoporosis	0.000178	0.00196	CcSEcCtD
Amifostine—Dermatitis—Calcitriol—osteoporosis	0.000178	0.00196	CcSEcCtD
Amifostine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000177	0.00195	CcSEcCtD
Amifostine—Somnolence—Conjugated Estrogens—osteoporosis	0.000177	0.00195	CcSEcCtD
Amifostine—Nausea—Alendronate—osteoporosis	0.000176	0.00194	CcSEcCtD
Amifostine—ENPP1—Disease—NFATC1—osteoporosis	0.000176	0.00285	CbGpPWpGaD
Amifostine—Malaise—Estradiol—osteoporosis	0.000176	0.00194	CcSEcCtD
Amifostine—Hypersensitivity—Risedronate—osteoporosis	0.000175	0.00193	CcSEcCtD
Amifostine—Syncope—Estradiol—osteoporosis	0.000175	0.00193	CcSEcCtD
Amifostine—ENPP1—Disease—DKK1—osteoporosis	0.000175	0.00283	CbGpPWpGaD
Amifostine—Nausea—Raloxifene—osteoporosis	0.000173	0.00191	CcSEcCtD
Amifostine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000173	0.0019	CcSEcCtD
Amifostine—Nausea—Ibandronate—osteoporosis	0.000172	0.00189	CcSEcCtD
Amifostine—Loss of consciousness—Estradiol—osteoporosis	0.000172	0.00189	CcSEcCtD
Amifostine—Feeling abnormal—Zoledronate—osteoporosis	0.00017	0.00188	CcSEcCtD
Amifostine—Hypertension—Estradiol—osteoporosis	0.000168	0.00186	CcSEcCtD
Amifostine—Pruritus—Risedronate—osteoporosis	0.000168	0.00186	CcSEcCtD
Amifostine—ENPP1—Disease—WNT1—osteoporosis	0.000168	0.00272	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—TPI1—osteoporosis	0.000168	0.00272	CbGpPWpGaD
Amifostine—Nausea—Calcitriol—osteoporosis	0.000168	0.00185	CcSEcCtD
Amifostine—Hypersensitivity—Pamidronate—osteoporosis	0.000167	0.00184	CcSEcCtD
Amifostine—Chest pain—Estradiol—osteoporosis	0.000166	0.00183	CcSEcCtD
Amifostine—Urticaria—Zoledronate—osteoporosis	0.000164	0.00181	CcSEcCtD
Amifostine—Discomfort—Estradiol—osteoporosis	0.000164	0.00181	CcSEcCtD
Amifostine—ENPP1—Disease—FGA—osteoporosis	0.000164	0.00265	CbGpPWpGaD
Amifostine—Body temperature increased—Zoledronate—osteoporosis	0.000163	0.0018	CcSEcCtD
Amifostine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000161	0.00178	CcSEcCtD
Amifostine—Pruritus—Pamidronate—osteoporosis	0.00016	0.00176	CcSEcCtD
Amifostine—Anaphylactic shock—Estradiol—osteoporosis	0.000159	0.00175	CcSEcCtD
Amifostine—ENPP1—Metabolism—P4HB—osteoporosis	0.000158	0.00256	CbGpPWpGaD
Amifostine—Urticaria—Conjugated Estrogens—osteoporosis	0.000158	0.00174	CcSEcCtD
Amifostine—Dizziness—Risedronate—osteoporosis	0.000157	0.00173	CcSEcCtD
Amifostine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000157	0.00173	CcSEcCtD
Amifostine—Shock—Estradiol—osteoporosis	0.000157	0.00173	CcSEcCtD
Amifostine—Tachycardia—Estradiol—osteoporosis	0.000155	0.00171	CcSEcCtD
Amifostine—ENPP1—Metabolism—GAPDH—osteoporosis	0.000155	0.00251	CbGpPWpGaD
Amifostine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000155	0.00171	CcSEcCtD
Amifostine—Rash—Ethinyl Estradiol—osteoporosis	0.000154	0.0017	CcSEcCtD
Amifostine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000154	0.00169	CcSEcCtD
Amifostine—Hypersensitivity—Zoledronate—osteoporosis	0.000152	0.00168	CcSEcCtD
Amifostine—Vomiting—Risedronate—osteoporosis	0.000151	0.00167	CcSEcCtD
Amifostine—ENPP1—Metabolism—RAP1A—osteoporosis	0.000151	0.00245	CbGpPWpGaD
Amifostine—Rash—Risedronate—osteoporosis	0.00015	0.00165	CcSEcCtD
Amifostine—Dermatitis—Risedronate—osteoporosis	0.00015	0.00165	CcSEcCtD
Amifostine—Dizziness—Pamidronate—osteoporosis	0.00015	0.00165	CcSEcCtD
Amifostine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000147	0.00162	CcSEcCtD
Amifostine—Pruritus—Zoledronate—osteoporosis	0.000146	0.00161	CcSEcCtD
Amifostine—ENPP1—Disease—ENO1—osteoporosis	0.000146	0.00236	CbGpPWpGaD
Amifostine—Nausea—Ethinyl Estradiol—osteoporosis	0.000145	0.0016	CcSEcCtD
Amifostine—Vomiting—Pamidronate—osteoporosis	0.000144	0.00158	CcSEcCtD
Amifostine—ENPP1—Disease—PSMA2—osteoporosis	0.000144	0.00233	CbGpPWpGaD
Amifostine—ENPP1—Disease—PSMA5—osteoporosis	0.000144	0.00233	CbGpPWpGaD
Amifostine—Rash—Pamidronate—osteoporosis	0.000143	0.00157	CcSEcCtD
Amifostine—Dermatitis—Pamidronate—osteoporosis	0.000143	0.00157	CcSEcCtD
Amifostine—Dyspnoea—Estradiol—osteoporosis	0.000142	0.00156	CcSEcCtD
Amifostine—Somnolence—Estradiol—osteoporosis	0.000142	0.00156	CcSEcCtD
Amifostine—Nausea—Risedronate—osteoporosis	0.000141	0.00156	CcSEcCtD
Amifostine—Pruritus—Conjugated Estrogens—osteoporosis	0.000141	0.00155	CcSEcCtD
Amifostine—Dizziness—Zoledronate—osteoporosis	0.000137	0.00151	CcSEcCtD
Amifostine—Nausea—Pamidronate—osteoporosis	0.000134	0.00148	CcSEcCtD
Amifostine—ENPP1—Disease—CALCA—osteoporosis	0.000134	0.00217	CbGpPWpGaD
Amifostine—Dizziness—Conjugated Estrogens—osteoporosis	0.000132	0.00145	CcSEcCtD
Amifostine—Vomiting—Zoledronate—osteoporosis	0.000131	0.00145	CcSEcCtD
Amifostine—Feeling abnormal—Estradiol—osteoporosis	0.000131	0.00145	CcSEcCtD
Amifostine—Rash—Zoledronate—osteoporosis	0.00013	0.00144	CcSEcCtD
Amifostine—Dermatitis—Zoledronate—osteoporosis	0.00013	0.00143	CcSEcCtD
Amifostine—Vomiting—Conjugated Estrogens—osteoporosis	0.000127	0.00139	CcSEcCtD
Amifostine—Urticaria—Estradiol—osteoporosis	0.000127	0.00139	CcSEcCtD
Amifostine—Body temperature increased—Estradiol—osteoporosis	0.000126	0.00139	CcSEcCtD
Amifostine—Rash—Conjugated Estrogens—osteoporosis	0.000125	0.00138	CcSEcCtD
Amifostine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000125	0.00138	CcSEcCtD
Amifostine—Nausea—Zoledronate—osteoporosis	0.000123	0.00135	CcSEcCtD
Amifostine—ENPP1—Metabolism—ENO1—osteoporosis	0.000122	0.00198	CbGpPWpGaD
Amifostine—ENPP1—Disease—KL—osteoporosis	0.000122	0.00197	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PSMA5—osteoporosis	0.00012	0.00195	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PSMA2—osteoporosis	0.00012	0.00195	CbGpPWpGaD
Amifostine—Nausea—Conjugated Estrogens—osteoporosis	0.000118	0.0013	CcSEcCtD
Amifostine—Hypersensitivity—Estradiol—osteoporosis	0.000117	0.00129	CcSEcCtD
Amifostine—Pruritus—Estradiol—osteoporosis	0.000113	0.00124	CcSEcCtD
Amifostine—Dizziness—Estradiol—osteoporosis	0.000105	0.00116	CcSEcCtD
Amifostine—Vomiting—Estradiol—osteoporosis	0.000101	0.00112	CcSEcCtD
Amifostine—Rash—Estradiol—osteoporosis	0.0001	0.00111	CcSEcCtD
Amifostine—Dermatitis—Estradiol—osteoporosis	0.0001	0.00111	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP19A1—osteoporosis	9.77e-05	0.00158	CbGpPWpGaD
Amifostine—ENPP1—Disease—ADCY5—osteoporosis	9.54e-05	0.00154	CbGpPWpGaD
Amifostine—Nausea—Estradiol—osteoporosis	9.46e-05	0.00104	CcSEcCtD
Amifostine—ENPP1—Disease—MTHFR—osteoporosis	8.77e-05	0.00142	CbGpPWpGaD
Amifostine—ENPP1—Disease—IRS2—osteoporosis	8.34e-05	0.00135	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ADCY5—osteoporosis	7.99e-05	0.00129	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GPX1—osteoporosis	7.96e-05	0.00129	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—MTHFR—osteoporosis	7.34e-05	0.00119	CbGpPWpGaD
Amifostine—ENPP1—Disease—IRS1—osteoporosis	7.28e-05	0.00118	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6R—osteoporosis	6.84e-05	0.00111	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—POMC—osteoporosis	5.87e-05	0.000951	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYC—osteoporosis	4.05e-05	0.000656	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFB1—osteoporosis	4.04e-05	0.000655	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6—osteoporosis	3.05e-05	0.000493	CbGpPWpGaD
